Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

Bavarian Nordic is now catching up to Valneva, whose Ixchiq vaccine became the world’s first licensed chikungunya vaccine when it was approved by the US Food and Drug Administration (FDA ...

If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.

SC Weaver is an inventor on a UTMB patent application describing IRES-attenuated alphavirus vaccines. Inviragen has obtained license to the patent for commercial development of a CHIK vaccine.

Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the ...

Robert F. Kennedy Jr., one of the most famous vaccine skeptics in the U.S., tried to distance himself from his decades of anti-vaccine sentiment during his Jan. 29 hearing to be confirmed as ...

Robert F. Kennedy Jr., one of the most famous vaccine skeptics in the U.S., tried to distance himself from his decades of anti-vaccine sentiment during his Jan. 29 hearing to be confirmed as secretary ...

Ixchiq Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company’s Ixchiq Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 20 ...